drugset
drugset / Trial / NCT00653393

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

NCT00653393 ↗

Phase 1 Completed 39 enrolled Par Pharmaceutical, Inc. SFBC Ft. Myers, Inc · collab
RandomizedCrossoverOpen-label

Summary

To compare the single-dose Bioavailability of Tranylcypromine and Parnate

Timeline

Start
2004-10
Primary completion
2004-11
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranylcypromine Small molecule 10 mg —

Indications

No indication recorded.